Orifarm

Orifarm Group, founded in 1994, is Europe's leading parallel importer of pharmaceuticals and a major supplier in Denmark. The group comprises companies engaged in import, production, re-packaging, distribution, registration, and sales of pharmaceuticals. Orifarm Group parallel imports medicines from EU countries, selling them in Denmark, Norway, Sweden, Finland, Germany, Holland, Austria, and the United Kingdom. It also supplies generic pharmaceuticals in the Nordics, offering products with identical active ingredients to original drugs at lower prices post-patent expiry.

Employing approximately 1,200 people, Orifarm Group manages extensive operations across its European markets. Its business model focuses on efficient supply chain management for pharmaceutical products, ensuring broad accessibility. The company's offerings include pharmaceuticals, generic drugs, vitamins, minerals, and food supplements, addressing diverse healthcare needs. Meet Orifarm's team to learn more about the professionals behind its extensive distribution network and market presence.

With a reported revenue of $776.4M, Orifarm Group operates within the Drug Stores & Pharmacies and Retail sectors. Its core products are pharmaceuticals, generic medications, and health supplements, solidifying its position as a significant entity in the European pharmaceutical landscape. The company's strategic emphasis on parallel importation and generic sales contributes to its mission of providing cost-effective healthcare solutions across its operational regions.